Yaso Therapeutics is an IND-approved, capital-efficient startup with a unique, multipurpose drug platform. Our mission is to improve women’s health autonomy, globally.
Family planning for women at every stage of their lives.
Innovative antiviral solutions for treatment and prevention of HSV1 and HSV2.
Our patented drug, PPCM, has broad activity against viruses and other pathogens.
257 million women worldwide lack modern contraception. Yaso offers a new promising non-hormonal contraceptive that is pleasant, effective, safe, affordable and accessible.